JP2022553703A5 - - Google Patents
Info
- Publication number
- JP2022553703A5 JP2022553703A5 JP2022523575A JP2022523575A JP2022553703A5 JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5 JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022523575 A JP2022523575 A JP 2022523575A JP 2022553703 A5 JP2022553703 A5 JP 2022553703A5
- Authority
- JP
- Japan
- Prior art keywords
- antigen
- binding fragment
- isolated antibody
- approximately
- pharmaceutical composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962926914P | 2019-10-28 | 2019-10-28 | |
| US62/926,914 | 2019-10-28 | ||
| US202063094170P | 2020-10-20 | 2020-10-20 | |
| US63/094,170 | 2020-10-20 | ||
| PCT/US2020/057635 WO2021086899A1 (en) | 2019-10-28 | 2020-10-28 | Anti-hemagglutinin antibodies and methods of use thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553703A JP2022553703A (ja) | 2022-12-26 |
| JP2022553703A5 true JP2022553703A5 (enExample) | 2023-09-26 |
| JP7611908B2 JP7611908B2 (ja) | 2025-01-10 |
Family
ID=73498317
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523575A Active JP7611908B2 (ja) | 2019-10-28 | 2020-10-28 | 抗血球凝集素抗体およびその使用方法 |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11773156B2 (enExample) |
| EP (1) | EP4051707A1 (enExample) |
| JP (1) | JP7611908B2 (enExample) |
| KR (1) | KR20220088446A (enExample) |
| CN (1) | CN114761428A (enExample) |
| AU (2) | AU2020374878B2 (enExample) |
| BR (1) | BR112022007923A2 (enExample) |
| CA (1) | CA3153944A1 (enExample) |
| CL (1) | CL2022001067A1 (enExample) |
| CO (1) | CO2022005281A2 (enExample) |
| IL (1) | IL292353A (enExample) |
| MY (1) | MY207220A (enExample) |
| PH (1) | PH12022550963A1 (enExample) |
| WO (1) | WO2021086899A1 (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2023201306A1 (en) | 2022-04-14 | 2023-10-19 | Invisishield Technologies Ltd. | Compositions for preventing or treating influenza infections |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| US20040101920A1 (en) | 2002-11-01 | 2004-05-27 | Czeslaw Radziejewski | Modification assisted profiling (MAP) methodology |
| US7850962B2 (en) | 2004-04-20 | 2010-12-14 | Genmab A/S | Human monoclonal antibodies against CD20 |
| US8257740B1 (en) | 2011-08-15 | 2012-09-04 | Gp Medical, Inc. | Pharmaceutical composition of nanoparticles |
| US8246995B2 (en) | 2005-05-10 | 2012-08-21 | The Board Of Trustees Of The Leland Stanford Junior University | Hydrophobic nanotubes and nanoparticles as transporters for the delivery of drugs into cells |
| JP5307708B2 (ja) | 2006-06-02 | 2013-10-02 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | ヒトｉｌ−６受容体に対する高親和性抗体 |
| MY192182A (en) | 2009-06-26 | 2022-08-04 | Regeneron Pharma | Readily isolated bispecific antibodies with native immunoglobulin format |
| SMT202600080T1 (it) | 2010-02-08 | 2026-03-09 | Regeneron Pharma | Topo con catena leggera comune |
| EP2814841A4 (en) * | 2012-01-31 | 2015-06-17 | Univ Osaka | HUMAN MONOCLONAL ANTIBODIES FOR WIDE PROTECTION AGAINST INFLUENZA B VIRUS AND METHOD OF USE THEREOF |
| EP2825036B1 (en) * | 2012-03-16 | 2018-05-02 | Regeneron Pharmaceuticals, Inc. | Histidine engineered light chain antibodies and genetically modified rodents for generating the same |
| TWI635098B (zh) | 2013-02-01 | 2018-09-11 | 再生元醫藥公司 | 含嵌合恆定區之抗體 |
| US10639370B2 (en) | 2014-02-04 | 2020-05-05 | Contrafect Corporation | Antibodies useful in passive influenza immunization, and compositions, combinations and methods for use thereof |
| JP6712428B2 (ja) * | 2014-02-04 | 2020-06-24 | コントラフェクト コーポレイション | インフルエンザ受動免疫に有用な抗体ならびにその使用のための組成物、組合せおよび方法 |
| TW201620932A (zh) * | 2014-03-27 | 2016-06-16 | 建南德克公司 | 抗－ｂ型流感病毒血球凝集素抗體及其使用方法 |
| MX392761B (es) * | 2014-07-15 | 2025-03-21 | Medimmune Llc | Anticuerpos anti-influenza b neutralizantes y usos de los mismos. |
| TWI702229B (zh) * | 2014-12-19 | 2020-08-21 | 美商再生元醫藥公司 | 流行性感冒病毒血球凝集素之人類抗體 |
| HUE056407T2 (hu) * | 2015-06-01 | 2022-02-28 | Medimmune Llc | Neutralizáló influenzaellenes kötõmolekulák és alkalmazásaik |
| CN106243218B (zh) | 2015-06-03 | 2020-05-15 | 厦门大学 | 抗Flu B的广谱单克隆抗体及其用途 |
| MX2018015755A (es) * | 2016-06-15 | 2019-08-29 | Icahn School Med Mount Sinai | Proteinas de hemaglutinina de virus de influenza y usos de las mismas. |
| US11254733B2 (en) * | 2017-04-07 | 2022-02-22 | Icahn School Of Medicine At Mount Sinai | Anti-influenza B virus neuraminidase antibodies and uses thereof |
| US11780907B2 (en) * | 2018-01-26 | 2023-10-10 | Regeneron Pharmaceuticals, Inc. | Human antibodies to influenza hemagglutinin |
-
2020
- 2020-10-28 IL IL292353A patent/IL292353A/en unknown
- 2020-10-28 US US17/082,375 patent/US11773156B2/en active Active
- 2020-10-28 BR BR112022007923A patent/BR112022007923A2/pt unknown
- 2020-10-28 PH PH1/2022/550963A patent/PH12022550963A1/en unknown
- 2020-10-28 WO PCT/US2020/057635 patent/WO2021086899A1/en not_active Ceased
- 2020-10-28 AU AU2020374878A patent/AU2020374878B2/en active Active
- 2020-10-28 EP EP20811191.4A patent/EP4051707A1/en active Pending
- 2020-10-28 JP JP2022523575A patent/JP7611908B2/ja active Active
- 2020-10-28 CA CA3153944A patent/CA3153944A1/en active Pending
- 2020-10-28 CN CN202080084529.XA patent/CN114761428A/zh active Pending
- 2020-10-28 MY MYPI2022002059A patent/MY207220A/en unknown
- 2020-10-28 KR KR1020227016672A patent/KR20220088446A/ko active Pending
-
2022
- 2022-04-27 CO CONC2022/0005281A patent/CO2022005281A2/es unknown
- 2022-04-27 CL CL2022001067A patent/CL2022001067A1/es unknown
-
2023
- 2023-08-21 US US18/453,207 patent/US20240083983A1/en active Pending
-
2025
- 2025-11-21 AU AU2025271140A patent/AU2025271140A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6711828B2 (ja) | インフルエンザ赤血球凝集素に対するヒト抗体 | |
| JP2018503361A5 (enExample) | ||
| JP2025172841A5 (enExample) | ||
| JP2023538369A5 (enExample) | ||
| JP2022543612A5 (enExample) | ||
| RU2015136392A (ru) | Композиции и способы, основанные на нейтрализующих антителах, доставляемых интраназально, для улучшенной терапевтической эффективности | |
| JP2021511043A5 (enExample) | ||
| IL275884B2 (en) | Human antibodies to influenza hemagglutinin | |
| JP2024527607A5 (enExample) | ||
| JP2024149479A (ja) | 黄熱を処置するための方法および組成物 | |
| CN115697378A (zh) | 用cgrp抑制剂治疗肺部损伤的方法 | |
| CN102216330B (zh) | 用于病毒所致的疾病的抗体药物组合物 | |
| JP2021523138A5 (enExample) | ||
| JP2023511956A5 (enExample) | ||
| JP2022553703A5 (enExample) | ||
| CN116406274B (zh) | 用于治疗冠状病毒的cd3抗体 | |
| AU2025271140A1 (en) | Anti-hemagglutinin antibodies and methods of use thereof | |
| JP2024177399A (ja) | 呼吸器疾患の治療のための汎ｅｌｒ＋ｃｘｃケモカイン抗体 | |
| JP2019508458A5 (enExample) | ||
| JP2023548603A5 (enExample) | ||
| WO2016189491A1 (en) | Novel formulation | |
| EA046393B1 (ru) | Антитела к гемагглютинину и их применение | |
| NZ793707A (en) | Combination of anti CD19 antibody with a BCL-2 inhibitor and uses thereof |